Are New Technologies for Detection and Treatment of Non-Muscle-Invasive Bladder Cancer (NMIBC) So Important? A Plea For Adoption by Teaching Programs to Improve Results After Standard White Light Transurethral Resection of NMIBC

被引：7
作者：
Brausi, Maurizio [1 ]
机构：
[1] B Ramazzini Hosp, Dept Urol, I-41012 Carpi Modena, Italy
来源：
EUROPEAN UROLOGY | 2012年 / 61卷 / 05期
关键词：
TUMORS; TA; EXPERIENCE; MANAGEMENT; TUR;
D O I：
10.1016/j.eururo.2012.02.023
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：914 / 916
页数：3
相关论文
共 10 条
[1]   Variability in the recurrence rate at first follow-up cystoscopy after TUR in stage Ta T1 transitional cell carcinoma of the bladder: A combined analysis of seven EORTC studies [J].
Brausi, M ;
Collette, L ;
Kurth, K ;
van der Meijden, AP ;
Oosterlinck, W ;
Witjes, JA ;
Newling, D ;
Bouffioux, C ;
Sylvester, RJ .
EUROPEAN UROLOGY, 2002, 41 (05) :523-530
[2]   Dedicated teaching programs can improve the quality of TUR of non-muscle-invasive bladder tumours (NMIBT): Experience of a single institution [J].
Brausi, M. A. ;
Gavioli, M. ;
Peracchia, G. ;
Viola, M. ;
Giliberto, G. L. ;
Simonini, G. ;
De Luca, G. ;
Borelli, A. ;
Bertom, V ;
Verrini, G. .
EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (03) :180-180
[3]   Approaches to the Management of Non-Muscle Invasive Bladder Cancer: A Review of Current Guidelines and Best Practice Recommendations from the International Bladder Cancer Group [J].
Brausi, Maurizio .
EUROPEAN UROLOGY SUPPLEMENTS, 2008, 7 (10) :615-617
[4]   Thermo-chemotherapy and electromotive drug administration of mitomycin C in superficial bladder cancer eradication - A pilot study on marker lesion [J].
Colombo, R ;
Brausi, M ;
Da Pozzo, LF ;
Salonia, A ;
Montorsi, F ;
Scattoni, V ;
Roscigno, M ;
Rigatti, P .
EUROPEAN UROLOGY, 2001, 39 (01) :95-100
[5]   Appearance of enhanced tissue features in narrow-band endoscopic imaging [J].
Gono, K ;
Obi, T ;
Yamaguchi, M ;
Ohyama, N ;
Machida, H ;
Sano, Y ;
Yoshida, S ;
Hamamoto, Y ;
Endo, T .
JOURNAL OF BIOMEDICAL OPTICS, 2004, 9 (03) :568-577
[6]   Stage progression in TA papillary urothelial tumors:: Relationship to grade, immunohistochemical expression of tumor markers, mitotic frequency and DNA ploidy [J].
Holmäng, S ;
Andius, P ;
Hedelin, H ;
Wester, K ;
Busch, C ;
Johansson, SL .
JOURNAL OF UROLOGY, 2001, 165 (04) :1124-1128
[7]   Prognostic factors in non-muscle-invasive bladder tumors - I. Clinical prognostic factors: A review of the experience of the EORTC genito-urinary group - II. Biologic prognostic markers [J].
Kurth, Karl-Heinz ;
Sylvester, Richard J. .
EUROPEAN UROLOGY SUPPLEMENTS, 2007, 6 (14) :789-799
[8]   A Randomized Prospective Trial to Assess the Impact of Transurethral Resection in Narrow Band Imaging Modality on Non-Muscle-Invasive Bladder Cancer Recurrence [J].
Naselli, Angelo ;
Introini, Carlo ;
Timossi, Luca ;
Spina, Bruno ;
Fontana, Vincenzo ;
Pezzi, Riccardo ;
Germinale, Francesco ;
Bertolotto, Franco ;
Puppo, Paolo .
EUROPEAN UROLOGY, 2012, 61 (05) :908-913
[9]   Expectant management of small, recurrent, noninvasive papillary bladder tumors [J].
Soloway, MS ;
Bruck, DS ;
Kim, SS .
JOURNAL OF UROLOGY, 2003, 170 (02) :438-441
[10]   Phase II trials in Ta, T1 bladder cancer. The marker tumour concept [J].
vanderMeijden, APM ;
Hall, RR ;
Kurth, KH ;
Bouffioux, C ;
Sylvester, R .
BRITISH JOURNAL OF UROLOGY, 1996, 77 (05) :634-637
1